Free Trial

iHuman (NYSE:IH) Trading Up 2.1% - Still a Buy?

iHuman logo with Consumer Discretionary background

Key Points

  • iHuman Inc. saw its stock price increase by 2.1%, with the last traded price at $2.95, down from a previous high of $2.98.
  • For its most recent quarter, iHuman reported earnings of $0.08 per share and revenues of $27.94 million, indicating a net margin of 12.46%.
  • Recent activity from hedge funds shows increased interest in iHuman, with notable positions established by Virtu Financial LLC and Acadian Asset Management LLC.
  • Interested in iHuman? Here are five stocks we like better.

iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report)'s share price was up 2.1% during mid-day trading on Wednesday . The stock traded as high as $2.98 and last traded at $2.95. Approximately 7,610 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 18,912 shares. The stock had previously closed at $2.89.

iHuman Stock Up 2.1%

The firm has a fifty day moving average of $2.84 and a 200-day moving average of $2.50. The firm has a market cap of $153.46 million, a P/E ratio of 10.17 and a beta of 0.39.

iHuman (NYSE:IH - Get Free Report) last posted its quarterly earnings results on Thursday, September 18th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $27.94 million for the quarter. iHuman had a return on equity of 11.59% and a net margin of 12.46%.

Hedge Funds Weigh In On iHuman

Hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in iHuman in the first quarter valued at about $26,000. Acadian Asset Management LLC acquired a new position in iHuman in the first quarter valued at about $32,000. Finally, Citadel Advisors LLC lifted its stake in iHuman by 24.3% in the fourth quarter. Citadel Advisors LLC now owns 47,683 shares of the company's stock valued at $81,000 after buying an additional 9,314 shares during the period. Institutional investors own 4.92% of the company's stock.

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.